Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexlansoprazole vs Esomeprazole for GERD
NCT03128736Phase 4Completed
- Sponsor
- Kaohsiung Medical University Chung-Ho Memorial Hospital
- Start
- Apr 2014
- Primary completion
- Feb 2016
- Modality
- Small Molecules
01
Overview
Phase 4, randomised, open-label trial of dexlansoprazole in gastroesophageal reflux disease (GERD) (2 arms), sponsored by Kaohsiung Medical University Chung-Ho Memorial Hospital. Primary endpoint: Rate of complete symptom resolution (CSR) at 1 week. Started Apr 2014; status: completed.
02
Drugs
dexlansoprazole
03
Conditions
gastroesophageal reflux disease (GERD)
Beyond the preview
Go deeper on NCT03128736.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03128736.